PYC Therapeutics (ASX:PYC) PB Ratio : 12.13 (As of Apr. 30, 2024)

View and export this data going back to 2005. Start your Free Trial

What is PYC Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-30), PYC Therapeutics's share price is A$0.097. PYC Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.01. Hence, PYC Therapeutics's PB Ratio of today is 12.13.

The historical rank and industry rank for PYC Therapeutics's PB Ratio or its related term are showing as below:

ASX:PYC' s PB Ratio Range Over the Past 10 Years
Min: 2.41 Med: 13.74 Max: 45.71
Current: 12.13

During the past 13 years, PYC Therapeutics's highest PB Ratio was 45.71. The lowest was 2.41. And the median was 13.74.

ASX:PYC's PB Ratio is ranked worse than
91.67% of 1308 companies
in the Biotechnology industry
Industry Median: 2.435 vs ASX:PYC: 12.13

During the past 12 months, PYC Therapeutics's average Book Value Per Share Growth Rate was 14.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -3.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 59.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 22.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PYC Therapeutics was 152.00% per year. The lowest was -37.00% per year. And the median was -12.60% per year.

Back to Basics: PB Ratio

PYC Therapeutics PB Ratio Historical Data

The historical data trend for PYC Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PYC Therapeutics PB Ratio Chart

PYC Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

PB Ratio

Get a 7-Day Free Trial

14.01

12.54

9.57

5.35

6.92

PYC Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial															8.89	5.35	9.74	6.92	13.59

Competitive Comparison of PYC Therapeutics's PB Ratio

For the Biotechnology subindustry, PYC Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PYC Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PYC Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where PYC Therapeutics's PB Ratio falls into.

PYC Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

PYC Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	0.097	/	0.008
	=	12.13

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

PYC Therapeutics (ASX:PYC) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

PYC Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of PYC Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

PYC Therapeutics (ASX:PYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (ASX:PYC) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009

Website

https://www.pyctx.com

PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.

PYC Therapeutics (ASX:PYC) Headlines

No Headlines